Vaccine News and Research

Latest Vaccine News and Research

Vaxxas' novel high-density microarray patch can deliver vaccines safely and effectively

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.

17 Mar 2020

Melbourne researchers show the body's ability to fight novel coronavirus

Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.

17 Mar 2020

mRNA vaccine against novel coronavirus goes on a trial in Seattle

A clinical trial for a vaccine to protect against the novel coronavirus commenced this Monday in the U.S.. If successful, this could mean an end to the current global pandemic of COVID-19 infections, feel experts.

16 Mar 2020

New method will enable production of tailor-made vaccines

Vaccines can be far more targeted and effective than they are today. A new method will allow us to develop new vaccines more cheaply and efficiently and perhaps get one step ahead of bacteria.

13 Mar 2020

'Flattening the curve' - why is it important for coronavirus?

With the emergence of the novel coronavirus and the propagation of the infectious disease COVID-19 around the world, everyone is talking about 'flattening the curve'. But what does this mean, and why is it so important?

12 Mar 2020

Negative information about vaccines remains readily available online

Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

12 Mar 2020

UK lab looks for volunteers to be infected with coronavirus

Amid the coronavirus disease (COVID-19) pandemic, scientists are asking for healthy volunteers to help in the development of the vaccine. Volunteers will be infected with the two strains of the common coronavirus.

12 Mar 2020

ZSL scientists call for investment in wildlife health research to prevent future pandemics

The UK should invest in better understanding of diseases in wildlife populations, and the routes to these becoming human diseases to drastically reduce the risk of future - possibly even worse - global pandemics like COVID-19.

12 Mar 2020

Vaccinating both boys and girls can help eliminate HPV infections

The human papillomavirus causes, amongst other diseases, cancer of the cervix and oropharynx. A Swedish-Finnish study published in The Journal of Infectious Diseases now shows that the most oncogenic HPV types can be eliminated, but only if both girls and boys are vaccinated.

12 Mar 2020

Could rushing a coronavirus vaccine cause more harm?

Amid the coronavirus disease (COVID-19) pandemic that is rapidly spreading worldwide, scientists are becoming more concerned that rushing vaccine production to prevent the infection may do more harm than good to patients.

12 Mar 2020

Potential targets for immune responses to novel coronavirus identified

Within two months, SARS-CoV-2, a previously unknown coronavirus, has raced around globe, infecting over a 100,000 people with numbers continuing to rise quickly.

11 Mar 2020

How to avoid coronavirus? Lessons from people whose lives depend on it

Andrea Amelse knows hand-washing.

11 Mar 2020

The second person cured from HIV goes public

In the 1980s and early 1990s, the outbreak of HIV and AIDS swept across the globe. Today, more than 70 million people have been infected with HIV, and about 35 million have died from AIDS since the start of the pandemic. However, scientific advances, such as the development of antiretroviral drugs, have enabled people with access to treatment to live long and healthy lives with HIV. But, there is still no vaccine and cure for it. In history, only two persons have been cleared of the infection, one in Berlin and now the second one in London.

10 Mar 2020

Immune systems of preemies can catch up

According to a new study published in March 2020 in the journal Nature Communications, babies born prematurely up to 32 weeks of pregnancy can quickly catch up on their immune system function after birth, bringing them to a state comparable to term infants.

9 Mar 2020

How does COVID-19 coronavirus compare to the 1918 Spanish flu?

The world has seen outbreaks, with some worst than others, but one thing is common, all these outbreaks result in loss of life and a global health crisis. One of the worst epidemics in the world was the 1918 Spanish flu. Now, the current coronavirus disease (COVID-19) outbreak is being compared to the Spanish flu that ravaged the world more than a century ago.

9 Mar 2020

Rotavirus vaccination not linked to type 1 diabetes mellitus risk

Rotavirus infection is thought to be a risk factor for type 1 diabetes mellitus (T1DM). The role played by live attenuated rotavirus vaccination in the risk of this condition in children is, therefore, an area of active research. A new study published in the journal JAMA Pediatrics in March 2020 debunks this concern.

9 Mar 2020

Scientists may have found a way to prevent coronavirus spread

Just like any other virus, the coronavirus needs a host to survive. Viruses enter the cells of the human body to cause disease by attaching to a specific receptor site on the host cell membrane. To do this, they attach to proteins in the capsid through glycoproteins found in the envelope of the virus.

8 Mar 2020

Individual responsibility to prevent the spread of COVID-19 is equally vital as government action

How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action, according to a new commentary from researchers at the University of Oxford and Imperial College London in the UK, and Utrecht University and the National Institute for Public Health and the Environment in the Netherlands.

7 Mar 2020

USask researchers receive almost $1 million to fight new coronavirus

A University of Saskatchewan research team and collaborating scientists from across the country have been awarded almost $1 million over two years to develop animal models and test vaccine candidates for effectiveness and safety against the new coronavirus (SARS-CoV-2).

7 Mar 2020

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Harvard University's Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Harvard's Department of Stem Cell and Regenerative Biology, announce the formation of a new NIH-funded Immuno-Engineering to Improve Immunotherapy Center.

7 Mar 2020